Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The sphingolipid ceramide is a bioactive signaling lipid that is thought to play important roles in modulating synaptic activity, in part by regulating the function of excitatory postsynaptic receptors. However, the molecular mechanisms by which ceramide exerts its effects on synaptic activity remain largely unknown. We recently demonstrated that a rapid generation of ceramide by neutral sphingomyelinase-2 (
nSMase2
; also known as "sphingomyelin
phosphodiesterase
-3") played a key role in modulating excitatory postsynaptic currents by controlling the insertion and clustering of NMDA receptors (Wheeler et al. [2009] J. Neurochem. 109:1237-1249). We now demonstrate that
nSMase2
plays a role in memory. Inhibition of
nSMase2
impaired spatial and episodic-like memory in mice. At the molecular level, inhibition of
nSMase2
decreased ceramide, increased PSD-95, increased the number of AMPA receptors, and altered the subunit composition of NMDA receptors. Our study identifies
nSMase2
as an important component for efficient memory formation and underscores the importance of ceramide in regulating synaptic events related to learning and memory.
...
PMID:Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice. 2062 93